Mega Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	490.26	518.29	399.83	239.1	208.45
Short-Term Investments	-	7.98	8.7	223.53	5.8
Cash & Short-Term Investments	490.26	526.27	408.53	462.63	214.25
Cash Growth	-6.84%	28.82%	-11.69%	115.93%	227.61%
Accounts Receivable	90.06	115.88	184.82	203.63	130.23
Other Receivables	-	-	5.53	0.04	0.71
Receivables	90.06	115.88	190.36	203.67	130.94
Inventory	4.61	4.41	3.51	3.28	2.97
Other Current Assets	40.67	21.22	16.69	15.78	9.95
Total Current Assets	625.59	667.78	619.08	685.36	358.11
Property, Plant & Equipment	79.26	94.05	46.91	51.13	62.24
Long-Term Investments	30.8	29.6	30.03	30.2	30.14
Other Intangible Assets	0.77	0.92	0.83	0.81	0.65
Long-Term Deferred Tax Assets	2.06	4.2	5.97	2.81	2.06
Other Long-Term Assets	-	-	2.88	1.88	0.37
Total Assets	738.48	796.54	705.7	772.18	453.57
Accounts Payable	25.43	39.54	34.76	29.2	26.88
Accrued Expenses	-	6.19	7.95	15.68	7.17
Current Portion of Long-Term Debt	2	1.91	-	-	2.65
Current Portion of Leases	-	10.62	6.48	6.22	8.44
Current Income Taxes Payable	1.72	0.6	0.12	6.53	0.2
Current Unearned Revenue	49.22	52.87	10.46	10.7	11.5
Other Current Liabilities	12.27	2.61	21.48	1.47	205.52
Total Current Liabilities	90.64	114.33	81.25	69.79	262.37
Long-Term Debt	18.73	20.72	-	-	-
Long-Term Leases	13.68	15.31	4.51	5.35	11.66
Long-Term Unearned Revenue	0.75	1.35	1.95	2.55	3.15
Total Liabilities	123.8	151.72	87.7	77.69	277.18
Common Stock	0.15	0.15	0.16	0.13	-
Additional Paid-In Capital	-	385.57	394.49	228.69	-
Retained Earnings	-	131.66	101.63	119.24	40.23
Treasury Stock	-27.98	-1.57	-	-	-
Comprehensive Income & Other	642.51	129.01	121.72	346.44	136.17
Shareholders' Equity	614.68	644.83	618	694.5	176.4
Total Liabilities & Equity	738.48	796.54	705.7	772.18	453.57
Total Debt	34.4	48.56	10.99	11.57	22.76
Net Cash (Debt)	455.86	477.71	397.55	451.06	191.49
Net Cash Growth	-4.57%	20.16%	-11.86%	135.56%	570.85%
Net Cash Per Share	2.20	2.26	1.93	3.54	-
Filing Date Shares Outstanding	207.42	237.77	239.23	200	-
Total Common Shares Outstanding	207.42	237.77	239.23	200	-
Working Capital	534.95	553.45	537.83	615.57	95.74
Book Value Per Share	2.96	2.71	2.58	3.47	-
Tangible Book Value	613.91	643.91	617.16	693.69	175.74
Tangible Book Value Per Share	2.96	2.71	2.58	3.47	-
Machinery	-	72.71	69.91	68.6	66.19
Construction In Progress	-	34.74	-	-	-
Leasehold Improvements	-	12.51	11.33	8.63	8.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.